Literature DB >> 18681482

Solution-phase parallel synthesis and biological evaluation of combretatriazoles.

Laura Cafici1, Tracey Pirali, Fabrizio Condorelli, Erika Del Grosso, Alberto Massarotti, Giovanni Sorba, Pier Luigi Canonico, Gian Cesare Tron, Armando A Genazzani.   

Abstract

Combretastatin A-4 is an antitumoral and antitubulin agent that is active only in its cis configuration. In the present manuscript, we have synthesized cis-locked combretastatins containing a triazole ring (combretatriazoles). To achieve this, we have developed a column chromatography-free parallel solution-phase synthesis that exploits the reaction between azides and alpha-keto phosphorus ylids, which is known to regioselectively generate the 1,5-disubstituted triazoles. The prepared compounds were screened as antitubulinic agents, allowing us to identify three new compounds with high potency, two of which show a new mechanism of action that induces cells to appear multinucleated and display a high number of mitotic spindles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18681482     DOI: 10.1021/cc800090d

Source DB:  PubMed          Journal:  J Comb Chem        ISSN: 1520-4766


  3 in total

1.  Synthesis, molecular docking and biological evaluation as HDAC inhibitors of cyclopeptide mimetics by a tandem three-component reaction and intramolecular [3+2] cycloaddition.

Authors:  Tracey Pirali; Valeria Faccio; Riccardo Mossetti; Ambra A Grolla; Simone Di Micco; Giuseppe Bifulco; Armando A Genazzani; Gian Cesare Tron
Journal:  Mol Divers       Date:  2009-05-28       Impact factor: 2.943

2.  Application of sequential Cu(I)/Pd(0)-catalysis to solution-phase parallel synthesis of combinatorial libraries of dihydroindeno[1,2-c]isoquinolines.

Authors:  Sarvesh Kumar; Thomas O Painter; Benoy K Pal; Benjamin Neuenswander; Helena C Malinakova
Journal:  ACS Comb Sci       Date:  2011-07-20       Impact factor: 3.784

3.  Methoxy and bromo scans on N-(5-methoxyphenyl) methoxybenzenesulphonamides reveal potent cytotoxic compounds, especially against the human breast adenocarcinoma MCF7 cell line.

Authors:  Myriam González; María Ovejero-Sánchez; Alba Vicente-Blázquez; Manuel Medarde; Rogelio González-Sarmiento; Rafael Peláez
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.